Richard Comshaw
Psychiatric/Mental Health · Rocky Hill, CTNPI 1639116957
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Alkermes, Inc. at 54.7% of the total. Reporting peaked in 2023 at $8,158 and has fallen 97.4% since, to $210 in 2024. Among psychiatric/mental health clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 420 payments — averaging $32.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$7K
- AbbVie$2K
- Lundbeck LLC$674
- Vanda Pharmaceuticals Inc.$608
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$604
- Teva Pharmaceuticals USA, Inc.$541
- plus $2K from 13 others
What the payments were for
- Speaking & faculty fees$5,51040%
- Travel & lodging$9137%
- Food & beverage$7,23853%
- Education$500%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 36 | $7,493 |
| AbbVie | 136 | $1,869 |
| Lundbeck LLC | 38 | $674 |
| Vanda Pharmaceuticals Inc. | 28 | $608 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 38 | $604 |
| Teva Pharmaceuticals USA, Inc. | 25 | $541 |
| Eisai Inc. | 41 | $433 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $348 |
| Otsuka America Pharmaceutical, Inc. | 20 | $345 |
| Neurocrine Biosciences, Inc. | 12 | $236 |
| Corium, LLC | 6 | $143 |
| Bausch Health US, LLC | 6 | $124 |
| Almatica Pharma LLC | 4 | $95 |
| Johnson & Johnson | 4 | $62 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Acadia Pharmaceuticals Inc | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$27,885
How this compares
$13,711 in reported general payments places this provider in the 95th percentile of 679 psychiatric/mental health providers in Connecticut.
See all psychiatric/mental health providers in Connecticut →
Other psychiatric/mental health in Rocky Hill
- Lynda EmardRocky Hill$10K
- Cristina MeehanNew Britain$224K
- Samantha MrazBridgeport$87K
- Philip FrickManchester$31K
- Gia SantoroWest Haven$25K
- Donna DraperDanbury$19K
- Zahida SairitupaDanbury$19K
- Hui HuNorwich$19K
- Patrick GagnonMilford$15K
- Max Greger-MoserNew Haven$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.